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Abstract
Background: The publication rate of neurosurgical guidelines has increased tremendously over the past decade; however, only
a small proportion of clinical decisions appear to be based on high-quality evidence.
Objective: The aim was to evaluate the evidence available within neurosurgery and its value within clinical practice according
to neurosurgeons.
Methods: A Web-based survey was sent to 2552 neurosurgeons, who were members of the European Association of Neurosurgical
Societies.
Results: The response rate to the survey was 6.78% (173/2552). According to 48.6% (84/173) of the respondents, neurosurgery
clinical practices are based on less evidence than other medical specialties and not enough high-quality evidence is available;
however, 84.4% (146/173) of the respondents believed neurosurgery is amenable to evidence. Of the respondents, 59.0% (102/173)
considered the neurosurgical guidelines in their hospital to be based on high-quality evidence, most of whom considered their
own treatments to be based on high-quality (level I and/or level II) data (84.3%, 86/102; significantly more than for the
neurosurgeons who did not consider the hospital guidelines to be based on high-quality evidence: 55%, 12/22; P<.001). Also,
more neurosurgeons with formal training believed they could understand, criticize, and interpret statistical outcomes presented
in journals than those without formal training (93%, 56/60 and 68%, 57/84 respectively; P<.001).
Conclusions: According to the respondents, neurosurgery is based on high-quality evidence less often than other medical
specialties. The results of the survey indicate that formal training in evidence-based medicine would enable neurosurgeons to
better understand, criticize, and interpret statistical outcomes presented in journals.
(Interact J Med Res 2018;7(2):e16)   doi:10.2196/ijmr.9617
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Introduction
Evidence-based neurosurgery is a paradigm of neurosurgical
practice in which the best available evidence is consulted to
establish the principles of diagnosis and treatment. These
principles are applied considering the neurosurgeon’s training
and experience, as well as being informed by the patient’s
individual circumstances and preferences, to produce the best
possible health outcomes [1]. Although evidence-based medicine
(EBM) is the gold standard in medicine [1-3], it is estimated
that only 10% to 25% of clinical decisions are based on
high-quality evidence [4], defined as level I and level II evidence
(see Table 1 for definitions) [5].
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Table 1. Levels of evidence in neurosurgery.
StudiesLevel of evidence
(1) Randomized controlled trial, (2) meta-analysis of randomized controlled trials with homogeneous resultsI
(1) Prospective comparative study (therapeutic), (2) meta-analysis of level II studies or level I studies with inconsistent resultsII
(1) Retrospective cohort study, (2) case-control study, (3) meta-analysis of level III studiesIII
(1) Case seriesIV
(1) Case report, (2) expert opinion, (3) personal observationV
In 2011, a new rating system, the Grading of Recommendations
Assessment, Development, and Evaluation (GRADE), was
developed, which offers an outcome-centric system for rating
the quality of evidence derived from different types of studies
[6]. The GRADE guidelines enable the rating of the quality of
evidence in systematic reviews and clinical guidelines, as well
as a determination of the strength of recommendations made in
these documents. To the best of our knowledge, neurosurgery
is currently still using the levels of evidence more often than
the GRADE guidelines.
Rothoerl et al [7]. and Yarascavitch et al [5] published
investigations into the levels of evidence in the neurosurgical
literature in 2003 and 2012, respectively. These studies assigned
a level of evidence to all published clinical papers in three major
neurosurgical journals for the years 1999 and 2009-2010,
respectively, graded according to the study design shown in
Table 1 [5,8,9]. The authors found that 22.8% and 10.3% of
evidence was considered higher-level evidence (level I or level
II). Level I evidence, from randomized controlled trials yielding
homogeneous results, was only found in 3.8% and 2.1% of the
papers evaluated in these two studies, respectively.
These studies suggest that surgeons are increasingly turning
their backs on research. Further evidence indicates that
compared with a decade or two ago, surgeons apply for and
receive fewer grants, publish less, and—perhaps most
perniciously—feel that research is not part of their role [10].
Involvement in research allows surgeons to develop rigor in
their everyday work and to judge, maintain, and improve the
quality of the work done by their peers.
The goal of this study is to investigate the opinion of
neurosurgeons about the evidence available in neurosurgical
practice and the extent to which this evidence is implemented
in clinical practice.
Methods
Recruitment
Evaluation by an ethical committee was not necessary for this
study. A survey was conducted among 2552 members of the
European Association of Neurosurgical Societies (EANS). The
survey asked the opinion of neurosurgeons regarding the levels
of evidence generated in neurosurgical studies, their
understanding of the levels of evidence, and to what extent
neurosurgeons implement evidence in clinical practice. The
survey was emailed directly to the members of the EANS by
the society’s administrative personnel. Data were collected over
a period of 3 weeks from the date of the first mailing. Two
reminders, each 1 week apart, were sent to the cohort.
Survey
The survey (Multimedia Appendix 1) was made using a Google
Inc program (Google Forms) and consisted of 13 sections
containing a total of 22 questions. Sections with multiple
questions within the survey were randomized to minimize the
influence of the sequence of questions on the answers. Levels
of evidence were used instead of ratings determined using the
GRADE recommendations because the levels are still more
commonly used by neurosurgeons to the best of our knowledge.
Participants were asked for their opinions on high-quality
evidence, the usability of the results of different research
methods in clinical practice, the amenability of neurosurgery
to evidence, the quality of guidelines in their hospital and of
the guidelines used by the neurosurgeons themselves, and the
most important factors for choosing between treatments. The
guidelines mentioned in the questionnaire were selected in a
previous study [11], in which a PubMed search was used to
identify the most recent guidelines available. These guidelines
were then characterized by the strength of their evidence [11].
This search covered the Agency for Healthcare Research and
Quality (AHRQ) National Guidelines Clearinghouse and
included both European guidelines and American guidelines.
The participants were also asked whether they had received
formal training in EBM, such as EU-ebm or CEBM, and if they
considered themselves capable of understanding, criticizing,
and interpreting statistical outcomes in journals.
Most questions consisted of a five-item Likert scale, which was
chosen because each item is of equal value, so the respondents
were scored rather than the items. The Likert scale was also
likely to yield highly reliable answers and is easy to read and
complete [12]. Some questions, for example about formal
training in EBM and the ability to understand, criticize, and
interpret statistical outcomes, were asked with a choice of Likert
scale answers to enable the neurosurgeons to “rate” their training
or ability to understand outcomes. The remaining questions had
binary answers or were choices between statements.
Participation was voluntary and completely anonymous, and
the purpose of the survey was explained to the participants.
Statistical Analyses
IBM SPSS version 22 (Armonk, NY, USA) was used for the
statistical analyses. For the continuous data, Student t tests were
used, whereas chi-square tests were used to analyze categorical
data. Some values, for example the number of years as a
neurosurgeon, were categorized before being statistically
examined. Comparisons were made between different groups
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of neurosurgeons. Multiple groups were formed based on the
answers to the questions asked and their opinions on different
aspects, and consisted of respondents responding with a positive
answer (“strongly agree,” “agree,” or “yes”), a negative answer
(“strongly disagree,” “disagree,” or “no”), or an indecisive
answer (“indifferent”) to particular questions. Afterwards,
comparisons were made between the answers and opinions of
certain groups for different aspects of neurosurgery. Values are
presented as a mean ±95% confidence interval (CI).
Results
The response rate was 6.78% (177 respondents) of the 2552
EANS members surveyed. All completed surveys contained
complete data and had no partial or missing responses. Four
respondents were excluded: three were still residents and one
response was sent twice. A final total of 173 completed surveys
(6.78%) were analyzed.
Respondent Statistics
Table 2 shows the demographics of the respondents. Their years
of experience varied. Most respondents (98.3%, 170/173) were
specialized in one or more subspecialties. Of these, 85.9%
(146/170) were specialized in two or more subspecialties, with
a mean of 3.2 per person (95% CI 2.97-3.43). A total of 57.2%
(99/173) of the respondents had one or more academic
qualifications, such as a professorship or a PhD. The majority
of the respondents (79.2%, 137/173) worked in one of 29
European countries, mostly Germany (10.4%, 18/173), the
Netherlands (7.5%, 13/173), Greece (6.4%, 11/173), or the
United Kingdom (5.8%, 10/173).
Table 2. Demographics of the respondents (N=173).
n (%)Demographics
Years working as a neurosurgeon
30 (17.3)1-5
46 (26.6)5-10
38 (22.0)10-15
13 (7.5)15-20
13 (7.5)20-25
16 (9.3)25-30
17 (9.8)>30
Academic qualificationsa
99 (57.2)Yesb
28 (23.0)Professor
67 (54.9)PhD
2 (1.6)MSPH
5 (4.1)MPH
20 (16.4)Other
Subspecialty
170 (98.3)Yesc
62 (11.7)Neurocritical care
70 (13.2)Cerebrovascular neurosurgery
14 (2.6)Neuroendovascular surgery
121 (22.9)Spinal neurosurgery
125 (23.6)Neurosurgical oncology
57 (10.8)Pediatric neurosurgery
35 (6.6)Peripheral nerve neurosurgery
30 (5.7)Stereotactic and functional neurosurgery
15 (2.8)Other
aPhD: Doctor of Philosophy; MPH: Master of Public Health; MSPH: Master of Science in Public Health.
b28.6% of the neurosurgeons who answered “yes” had more than one academic qualification, with a mean of 1.2 per person (95% CI 1.11-1.29).
c85.9% of the neurosurgeons who answered “yes” had more than one subspecialty, with a mean of 3.2 per person (95% CI 2.97-3.43).
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The remaining 36 respondents (20.8%, 36/173) worked in one
of 18 non-European countries, particularly in countries in the
Middle East (11.6%, 20/173), such as Saudi Arabia (2.9%,
5/173), Pakistan (2.3%, 4/173), and Iraq (1.7%, 3/173). The
remaining respondents came mainly from Mexico (1.7%, 3/173),
India (1.7%, 3/173), and the United States (1.2%, 2/173).
Evaluation Outcomes
Table 3 shows the opinions of the respondents regarding the
levels of evidence and the use of EBM in clinical practice. Of
the 173 respondents, 84 (48.6%) considered level I or level I
and level II evidence to be of high quality. Figure 1 shows the
levels of evidence used by neurosurgeons in clinical practice;
most respondents implemented all levels of evidence into their
clinical practice. The results of randomized controlled trials
(RCTs) with inconsistent, but promising, results were used by
fewer than half of the respondents (45.7%, 79/173; Tables 4
and 5).
Every participant indicated the guidelines they used most often,
to a maximum of three guidelines (Table 6). The level of
evidence generated by the research underpinning each guideline
is shown. Guidelines considering the surgical management of
traumatic brain injury were most commonly used (39.3%,
68/173), followed by those for severe traumatic brain injury
(38.2%, 66/173) and subarachnoid hemorrhage (38.2%, 66/173).
Table 6 also shows the number of neurosurgeons using the
guideline who subspecialized in the corresponding area of
neurosurgery. The numbers of neurosurgeons specializing in
the areas corresponding to the three most-used guidelines did
not comprise a large percentage of the total number of
neurosurgeons using these guidelines (48.5%, 48.5%, and 78.8%
of neurosurgeons specializing in the surgical management of
traumatic brain injury, severe traumatic brain injury, and
subarachnoid hemorrhage, respectively). This may be because
these three areas are all critical conditions that require immediate
care; therefore, it is likely that most neurosurgeons will use
these guidelines even if it is not their subspecialty.
Table 3. Levels of evidence considered by neurosurgeons to be of high quality and usable in clinical practice.
Considered to be of high quality and usable in clinical practice, n (%)Levels of evidence
3 (1.7)None
15 (8.7)Level I
69 (39.9)Level I and level II
53 (30.6)Level I, level II, and level III
2 (1.2)Level I, level II, level III, and level IV
31 (17.9)All levels (Level I-V)
Figure 1. Levels of evidence used by neurosurgeons in clinical practice. The results are presented on a five-item Likert scale: (1) strongly agree, (2)
agree, (3) indifferent, (4) disagree, or (5) strongly disagree.
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Table 4. Studies used by the participants in clinical practice. Scores were given from 1 (strongly disagree) to 5 (strongly agree).
Studies used, mean (95% CI)StudiesLevel of evidence
3.8 (2.14-5.46)(1) RCTa, (2) meta-analysis of RCTs with homogeneous resultsI
3.9 (2.48-5.32)(1) Prospective comparative study (therapeutic)II
3.9 (2.34-5.46)(2) Meta-analysis of level II studiesII
3.3 (1.54-5.06)(3) Meta-analysis of level I studies with inconsistent resultsII
3.8 (2.36-5.24)(1) (Meta-analysis of) retrospective cohort studyIII
3.6 (2.06-5.14)(2) Case-control studyIII
3.7 (2.02-5.38)(1) Case seriesIV
3.5 (1.64-5.36)(1) Case report, (2) expert opinion, (3) personal observationV
aRCT: randomized controlled trial.
Table 5. Summary of the overall survey results (N=173).
Indifferent, n (%)Strongly agree or agree, n (%)Survey item
Factors important for choosing a treatment
0 (0.0)172 (99.4)Clinical experience is an important factor for choosing a treatment
10 (5.8)160 (92.5)Research is an important factor for choosing a treatment
39 (22.4)124 (71.7)Knowledge from patients and carers is an important factor for choosing a treatment
42 (24.3)123 (71.1)Local context and environment are important factors for choosing a treatment
Use of research in clinical practice
34 (19.7)134 (77.5)I use prospective cohort studies in clinical practice
35 (20.2)130 (75.1)I use meta-analysis of prospective cohort studies in clinical practice
39 (22.5)126 (72.9)I use (meta-analysis of) retrospective cohort studies in clinical practice
41 (23.7)122 (70.5)I use (meta-analysis of) RCTsa with homogeneous results in clinical practice
42 (24.3)113 (65.3)I use case-control studies in clinical practice
47 (27.2)111 (64.2)I use case series in clinical practice
52 (30.1)98 (56.6)I use case reports, expert opinions, or personal observations in clinical practice
66 (38.2)79 (45.7)I use (meta-analysis of) RCTs with inconsistent, but promising, results in clinical practice
Guidelines and treatment options
26 (15.0)129 (74.5)Treatment options I use are based on high-quality evidence
3 (1.7)c126 (72.8)bThe neurosurgeons at my hospital are involved in the process of setting up the neurosurgical
guidelines for my hospital
49 (28.3)102 (59.0)Guidelines at my hospital are based on high-quality evidence
Training
19 (11.1)87 (80.3)I can understand, criticize, and interpret statistical outcomes in journals
29 (16.8)60 (34.7)I have received formal training in EBMd
19 (11.0)146 (84.4)Neurosurgery is amenable to evidence
aRCT: randomized controlled trial.
bQuestion was answered with “yes.”
cQuestion was answered with “other.”
dEBM: evidenced-based medicine.
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Table 6. Most-used neurosurgical guidelines (N=173).
Neurosurgeons using this
guideline subspecialized in
this field, n (%)
Neurosurgeons using
this guideline, n (%)
Level of evidence in research
used to develop guideline [11]
Guidelines
—150 (86.7)—aHead injury
33 (49)68 (39.3)ModerateSurgical management of traumatic brain injury
32 (49)66 (38.2)ModerateSevere traumatic brain injury
7 (78)9 (5.2)ModeratePediatric traumatic brain injury
4 (44)7 (4.0)High/moderateMild traumatic brain injury
—136 (78.6)—Spine
32 (84)38 (22.0)All levelsLumbar disk herniation
19 (100)19 (11.0)ModerateCervical spine and spinal cord injury
15 (88)17 (9.8)Moderate/lowDegenerative lumbar spondylolisthesis
10 (77)13 (7.5)Moderate/lowDegenerative lumbar stenosis
11 (100)11 (6.4)ModerateDegenerative cervical spine disease
10 (91)11 (6.4)All levelsLumbar spine fusion
10 (100)10 (5.8)All levelsCervical radiculopathy and degenerative disease
7 (78)9 (5.2)All levelsAntibiotic prophylaxis in spine surgery
4 (67)6 (3.5)HighIntraoperative spinal monitoring
1 (100)1 (0.6)ModerateSomatosensory evoked potentials
1 (100)1 (0.6)Moderate/lowVertebral osteomyelitis, diskitis, and epidural abscess
—96 (55.5)—Vascular
52 (79)66 (38.2)All levelsSubarachnoid hemorrhage
19 (83)23 (13.3)HighIntracerebral hemorrhage
6 (86)7 (4.0)High/moderateExtracranial carotid disease
—81 (46.8)—Tumor
52 (87)60 (34.7)ModerateGlioblastoma
18 (86)21 (12.1)High/moderateBrain metastases
—11 (6.4)—Functional
9 (90)10 (5.8)High/moderateDeep brain stimulation
0 (0)1 (0.2)ModerateVagal nerve stimulation
—22 (4.4)—Other
14 (78)18 (3.6)ModerateHydrocephalus
1 (25)4 (0.8)High/moderateCarpal tunnel syndrome
aNot applicable.
According to 84.4% of the neurosurgeons (146/173),
neurosurgery is amenable to evidence (Table 5); however, nearly
half of the respondents (48.6%, 84/173) believed that
neurosurgery is less based on evidence than other medical
specialties. Despite this, 74.6% of the respondents (129/173)
consider their treatments to be based on level I and/or level II
evidence. Of those who believed neurosurgery is amenable to
evidence, 78.8% (115/146 respondents) considered their
treatments to be based on level I and/or level II evidence,
whereas significantly fewer (25%, 2/8) of those who did not
believe neurosurgery is amenable to evidence considered their
research to be based on such high-quality evidence (P=.048).
Of the most-used neurosurgical guidelines (Table 6), only 9.78%
(242/2469) were based on level I evidence, whereas 20.43%
(545/2668) were based on level II evidence.
Of the 129 respondents who believed their treatments were
based on high-quality evidence, 50.4% (65/129) considered
level I and/or level II to be high-quality evidence, whereas
significantly fewer (39%, 7/18) of the respondents who did not
consider their treatments to be based on high-quality evidence
considered level I and/or level II to be high quality (P=.02).
Most respondents (72.8%,126/173) were involved in the process
of setting up the neurosurgical guidelines in their hospital. More
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than half (59.0%, 102/173) of the respondents considered the
neurosurgical guidelines of their hospital to be based on
high-quality evidence. Of those who were involved in their
establishment, 65.9% (83/126) considered the guidelines of
their hospital to be based on high-quality evidence, compared
with just 43% (20/47) of those who were not involved (P=.02).
Of the 59.0% (102/173) of respondents who considered the
neurosurgical guidelines in their hospital to be based on
high-quality evidence, 84.3% (86/102) considered their own
treatments to be based on level I and/or level II evidence,
whereas 55% (12/22) of the respondents who did not consider
hospital guidelines to be based on high-quality evidence
considered their own treatments to be based on level I and/or
level II evidence (P<.001).
Only 34.7% (60/173) of the respondents said they had received
formal training in EBM. Of those who received formal training,
76% (46/60) considered their own treatments to be based on
level I and/or level II evidence, whereas 85% (71/84) of those
without formal training believed their treatments were based on
this level of evidence (P=.03).
The majority of respondents (80.3%, 139/173) said they could
understand, criticize, and interpret statistical outcomes in
medical research. This response was more common for
respondents who received formal training (93%, 56/60) than
for those without formal training (68%, 57/84; P<.001). There
was no difference between the number of respondents with and
without additional academic qualifications who stated that they
could understand, criticize, and interpret statistical outcomes
(85%, 84/99 and 74%, 55/74, respectively; P=.16).
All participants had the option to add their own comments at
the end of the survey. The most frequent comment was that the
lack of evidence is an important issue in neurosurgery.
Neurosurgeons also said that RCTs are expensive and difficult
to perform, although well-designed prospective comparative
studies could be equally informative and easier to run. They
therefore concluded that dismissing study designs other than
RCTs when developing neurosurgical guidelines is holding back
neurosurgery.
Discussion
This study is unique because it is, to the best of our knowledge,
the first to evaluate the opinion of neurosurgeons in several
countries regarding the use of evidence in neurosurgery. Level
I and level II evidence is considered high quality; however,
despite a worldwide acceptance of this classification, only 48.5%
of the respondents (84/173) considered either level I or levels
I and II to be high quality. Moreover, all levels of evidence seem
to be used by the majority of neurosurgeons. Several
neurosurgeons commented that the lack of evidence is an
important issue in neurosurgery.
Indisputable advancements in neurosurgery have been
traditionally based on technical innovations advocated by
pioneers without rigid assessment in clinical trials; therefore,
changes in clinical practice have frequently been
technology-driven rather than strictly evidence-based [13].
Everyday clinical management in neurosurgery does not,
therefore, always seem to comply with the best available
evidence.
Since 1970, the rate of increase in the publication of guidelines
in all specialties has outpaced neurosurgery [11]; however, in
the past 5 years, the number of guidelines published per year
in neurosurgery has increased at the same rate as all specialties
[11]. The available literature shows that neurosurgery uses a
higher percentage of high-level evidence than some other
specialties, including general plastic surgery [14] and
maxillofacial surgery [15]; however, neurosurgery is still lagging
behind many other specialties, including orthopedics [16],
ophthalmology [17], otolaryngology [18], esthetic surgery [19],
and urology [20]. The situation in other fields resembles that
of neurosurgery; for example, 12.2% of the treatment for atrial
fibrillation is based on level I and II evidence [21], although we
could not find any data on the levels of evidence used in the
treatment of cardiovascular disease as a whole. When comparing
neurosurgery with oncology, we discovered that oncology uses
the AGREE (Appraisal of Guidelines for Research and
Evaluation) rating of guidelines [22-25]. The AGREE domains
(scope and purpose, stakeholder involvement, rigor of
development, clarity of presentation, applicability, and editorial
independence) [26] are not comparable with the levels of
evidence, in which studies are graded by study design.
Of the respondents who participated in this study, 25.4%
(44/173) did not think that, or know whether, the treatment
options they use are based on high-quality evidence. Ducis et
al [11] investigated the quality of the guidelines used in
neurosurgery clinical practice. In neurosurgery, 24.4% of the
guidelines were based mainly on level I recommendations,
whereas for vascular neurosurgery guidelines this percentage
is significantly higher: 51.9%. Some other specialties have
numbers of level I-based recommendations similar to
neurosurgery, including endocrinology [27], infectious diseases
[28], and hepatology [29]. Vascular neurosurgery is the
subspecialty with the highest publication rate in neurosurgery
[5], and vascular neurosurgery guidelines are the third most
commonly used in clinical practice (according to Table 6).
Guidelines relating to traumatic brain injuries are the most used
according to the respondents, but this subspecialty accounted
for just 6.4% of neurosurgery publications between 2009 and
2010 [5]. The level I-based recommendations for traumatic
brain injury guidelines accounted for only 5.6% of all
recommendations [11], significantly less than the level I-based
recommendations for spine guidelines (10.0%) and vascular
guidelines (51.0%), as assessed with a chi-square test (P<.001).
One participant commented that neurosurgery is currently based
more on eminence than on evidence. Eminence refers to a
clinical decision that is made solely by relying on the opinion
of a medical specialist or any prominent health professional
rather than the critical appraisal of the scientific evidence
available [30]. Evidence is an integration of clinical knowledge
and skills with the best critically appraised research available,
as well as patient values and preferences, in order to make a
clinical decision [30]. With the lack of evidence available to
neurosurgeons, neurosurgery seems indeed to be based more
on eminence than evidence in some cases.
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Another neurosurgeon commented that the current definition
of evidence-based neurosurgery is in dire need of rigorous
update and expansion. A common misunderstanding of EBM
is that a lack of available evidence means a lack of RCTs [31].
EBM evaluates the quality of evidence, based primarily on the
likelihood that the evidence is biased. A powerful RCT is the
best standard for evaluating this inherent bias, but it does not
follow that only RCTs can be used to justify clinical practice
in EBM; rather, EBM requires that we attempt to audit our
decisions by obtaining the highest level of evidence ethically
or logistically possible [31,32].
The differences in the confidence of neurosurgeons with and
without formal training in EBM to adequately interpret the
statistical outcomes presented in the literature was striking. Only
35% of the responding neurosurgeons (60/173) had received
formal training in EBM and although it seems low, it is similar
to that described in orthopedic surgery [33]. The lack of EBM
training in neurosurgery has already been noted elsewhere; the
University of Western Ontario in London, ON, Canada [34],
and the American Accreditation Council for Graduate Medical
Education [31] recently incorporated EBM into the curriculum
for residency training programs in neurosurgery. Since EBM is
based on the implementation of correctly interpreted research
results, our findings may represent an argument for the
introduction of more formal EBM training in the medical
curriculum and supplementary training for neurosurgical
departments.
A major strength of this study is the broad representation of the
opinions of neurosurgeons worldwide through the involvement
of the EANS. EANS has a large number of members all over
the world. The membership of EANS is primarily located in
Europe, but neurosurgeons from all countries are permitted to
join. However, some potential limitations should also be
discussed. First, due to the low response rate, selection bias
cannot be precluded, which hampers the generalizability of our
results. For external email surveys, a response rate between
10% to 25% is usually considered the average [35,36]. The
response rate to our survey was a little lower than average,
which might be caused by a general lack of interest by
neurosurgeons or because they did not recognize the importance
of this study. Bias could have been introduced because the
survey may have been selectively answered by those who
consider EBM important, specifically by those who were trained
in EBM, involved in innovation and guidelines, or opinion
leaders. Second, the participants of the survey may have chosen
to provide socially desirable answers; however, this was
counteracted by emphasizing the anonymity of the survey. A
third potential issue is that neurosurgery is in the middle of
transitioning from rating the guidelines using levels of evidence
to rating them with the GRADE guidelines. We choose to use
the levels of evidence here because they are currently more
widely used by neurosurgeons; however, this could have been
confusing for those who have already begun to use the GRADE
guidelines.
The transition from using levels of evidence to the GRADE
system is an important change in all medical specialties,
including neurosurgery. The literature available about the
evaluation of evidence in neurosurgery does not include the
new system and is, therefore, in need of expansion and updating.
The GRADE guidelines offer some major advantages over the
levels of evidence, as they enable the rating of evidence in
systematic reviews and guidelines and the grading of the strength
of recommendations made in guidelines. Moreover, the GRADE
system offers a transparent and structured process for developing
and presenting summaries of evidence in systematic reviews
and guidelines in health care, and for carrying out the steps
involved in developing recommendations [6].
There are major gaps between the current definition of
high-quality evidence (level I and level II) and neurosurgeons’
opinions of evidence. Neurosurgeons are willing to base their
clinical decisions on more than just RCTs, relying on
lower-quality evidence. The transition to the GRADE system
is one way to overcome this issue because these guidelines are
outcome-centric and do not rate each study as a single unit. In
the GRADE approach, RCTs are initially considered to be
high-quality evidence and observational studies are initially
considered low-quality evidence supporting estimates of
intervention effects. Five factors may lead the ratings to be
decreased, whereas three other factors may lead to an increased
rating. Ultimately, the quality of evidence for each outcome
falls into one of four categories, from high to very low [6].
EBM is important when choosing between treatments for
patients; however, shared decision making (SDM) was also
developed alongside the introduction of EBM. According to
71.7% (124/173) of the respondents of this study, knowledge
gained from patients and carers was an important factor in the
selection of a treatment, whereas 22.5% of the respondents
(39/173) were indifferent and 5.8% (10/173) did not believe
that the knowledge of patients and carers was an important
factor when choosing a treatment. Evidence from trials has
shown that engaged patients consume less health care resources
[37,38]; furthermore, when doctors are too focused on EBM,
preference misdiagnoses (also known as silent misdiagnoses)
can be made, causing the patient to receive an unwanted
treatment [39]. EBM is important but has to be combined with
SDM to give patients the right treatment. Learning to combine
these two sides of medicine could be an important development
in all specialties, leading to the optimization of health care for
patients.
Understanding EBM is key to using it correctly in practice. This
study shows that relatively few neurosurgeons have received
formal training in EBM; thus, more training in EBM, both in
the medical curriculum for residents and at neurosurgical
departments, would enable neurosurgeons to improve their
abilities to better facilitate the implementation of statistical
results into clinical practice. It would be interesting to perform
this research on a larger scale, including a wider multinational
sample in the future.
According to the respondents, neurosurgery is less commonly
based on high-quality evidence than other medical specialties.
The results of the survey suggest that providing more formal
training in EBM is desirable, enabling neurosurgeons to better
understand, criticize, and interpret the statistical outcomes
presented in journals.
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